Literature DB >> 7680980

Somatomedin-1 (insulin-like growth factor-I) in clinical use. Facts and potential.

Z Laron1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 7680980     DOI： 10.2165/00003495-199345010-00001

Source DB:  PubMed          Journal:  Drugs        ISSN： 0012-6667            Impact factor:   9.546


× No keyword cloud information.
  52 in total

1.  A personal history of the origin of the somatomedin hypothesis and recent challenges to its validity.

Authors:  W H Daughaday
Journal:  Perspect Biol Med       Date:  1989       Impact factor: 1.416

2.  Characterization of the human growth hormone receptor gene and demonstration of a partial gene deletion in two patients with Laron-type dwarfism.

Authors:  P J Godowski; D W Leung; L R Meacham; J P Galgani; R Hellmiss; R Keret; P S Rotwein; J S Parks; Z Laron; W I Wood
Journal:  Proc Natl Acad Sci U S A       Date:  1989-10       Impact factor: 11.205

Review 3.  Insulin-like growth factor (IGF) binding proteins: the role of serum IGFBPs in regulating IGF availability.

Authors:  R C Baxter
Journal:  Acta Paediatr Scand Suppl       Date:  1991

4.  Administration of growth hormone to patients with familial dwarfism with high plasma immunoreactive growth hormone: measurement of sulfation factor, metabolic and linear growth responses.

Authors:  Z Laron; A Pertzelan; M Karp; A Kowadlo-Silbergeld; W H Daughaday
Journal:  J Clin Endocrinol Metab       Date:  1971-08       Impact factor: 5.958

Review 5.  Deficiencies of growth hormone and somatomedins in man.

Authors:  Z Laron
Journal:  Spec Top Endocrinol Metab       Date:  1983

6.  Elimination characteristics of intravenously administered rIGF-I in Laron-type dwarfs.

Authors:  B Klinger; M Garty; A Silbergeld; Z Laron
Journal:  Dev Pharmacol Ther       Date:  1990

7.  Growth hormone facilitates ovulation induction by gonadotrophins.

Authors:  R Homburg; A Eshel; H I Abdalla; H S Jacobs
Journal:  Clin Endocrinol (Oxf)       Date:  1988-07       Impact factor: 3.478

8.  IGF binding protein 3 in patients with Laron type dwarfism: effect of exogenous rIGF-I.

Authors:  Z Laron; B Klinger; W F Blum; A Silbergeld; M B Ranke
Journal:  Clin Endocrinol (Oxf)       Date:  1992-03       Impact factor: 3.478

9.  Serum growth hormone binding protein activity in healthy neonates, children and young adults: correlation with age, height and weight.

Authors:  A Silbergeld; L Lazar; B Erster; R Keret; R Tepper; Z Laron
Journal:  Clin Endocrinol (Oxf)       Date:  1989-09       Impact factor: 3.478

Review 10.  Hormone families: pancreatic hormones and homologous growth factors.

Authors:  T L Blundell; R E Humbel
Journal:  Nature       Date:  1980-10-30       Impact factor: 49.962
View more
  2 in total

Review 1.  Clinical use of somatomedin-1: yes or no?

Authors:  Z Laron
Journal:  Paediatr Drugs       Date:  1999 Jul-Sep       Impact factor: 3.022

Review 2.  Growth hormone secretagogues. Clinical experience and therapeutic potential.

Authors:  Z Laron
Journal:  Drugs       Date:  1995-10       Impact factor: 9.546
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.